发明名称 |
DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE |
摘要 |
The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease. |
申请公布号 |
US2014219986(A1) |
申请公布日期 |
2014.08.07 |
申请号 |
US201214004335 |
申请日期 |
2012.03.08 |
申请人 |
Greene Douglas Stuart;Valenzano Kenneth Joseph |
发明人 |
Greene Douglas Stuart;Valenzano Kenneth Joseph |
分类号 |
A61K47/22;A61K38/47 |
主分类号 |
A61K47/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating Fabry disease in a subject, the method comprising administering from about 50 mg to about 600 mg of 1-deoxygalactonojirimycin and an effective amount of α-Gal A enzyme replacement therapy to a patient in need thereof. |
地址 |
Newton PA US |